Form 8-K - Current report:
SEC Accession No. 0001193125-26-265835
Filing Date
2026-06-10
Accepted
2026-06-10 16:11:13
Documents
9
Period of Report
2026-06-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K prld-20260609.htm   iXBRL 8-K 77650
  Complete submission text file 0001193125-26-265835.txt   207154

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prld-20260609.xsd EX-101.SCH 45171
12 EXTRACTED XBRL INSTANCE DOCUMENT prld-20260609_htm.xml XML 4543
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 261079773
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)